Healthcare Technology Report September 4, 2024

Tempus AI, a pioneer in precision medicine and artificial intelligence, has extended its partnership with Remix Therapeutics, a clinical-stage biotechnology company that specializes in the development of small...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Partnerships, Pharma / Biotech, Precision Medicine, Technology, Trends
Hate needles? Lilly’s weight-loss pill could get FDA approval next year, CEO says
Google DeepMind CEO: AI-Designed Drugs Coming to Clinical Trials in 2025
Moderna gets $590M from US government for bird flu vaccine
Why costly gene therapy is top of mind for benefits administrators
CEPI provides $6.2m to push first mRNA-based Rift Valley fever vaccine into trial

Share This Article